Biomedical Engineering Reference
In-Depth Information
[134]
Wescoe KE, RC Schugar, CR Chu and BM Deasy (2008). The role of the biochemical and
biophysical environment in chondrogenic stem cell differentiation assays and cartilage tissue
engineering. Cell Biochemistry and Biophysics 52: 85-102.
[135]
Kim S and H Von Recum (2008). Endothelial stem cells and precursors for tissue engineering:
cell source, differentiation, selection, and application. Tissue Engineering Part B 14: 133-147.
[136]
Inanc B, AE Elcin and YM Elcin (2008). Human embryonic stem cell differentiation on tissue
engineering scaffolds: Effects of NGF and retinoic acid induction. Tissue Engineering Part A
14: 955-964.
[137]
Xiao W, H Fu, MN Rahaman, Y Liu and BS Bal (2013). Hollow hydroxyapatite microspheres:
a novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic
protein-2 in bone regeneration. Acta Biomaterialia 9: 8374-8383.
[138]
Lee HJ, AN Koo, SW Lee, MH Lee and SC Lee (2013). Catechol-functionalized adhesive
polymer nanoparticles for controlled local release of bone morphogenetic protein-2 from
titanium surface. Journal of Controlled Release 170: 198-208.
[139]
Xie J, H Wang, Y Wang, F Ren, W Yi, K Zhao, Z Li, Q Zhao, Z Liu, H Wu, C Gu and D Yi
(2013). Induction of angiogenesis by controlled delivery of vascular endothelial growth factor
using nanoparticles. Cardiovascular Therapeutics 31: e12-e18.
[140]
Simon-Yarza T, FR Formiga, E Tamayo, B Pelacho, F Prosper and MJ Blanco-Prieto (2012).
Vascular endothelial growth factor-delivery systems for cardiac repair: an overview.
Theranostics 2: 541-552.
[141]
Kaigler D, EA Silva and DJ Mooney (2013). Guided bone regeneration using injectable
vascular endothelial growth factor delivery gel. Journal of Periodontology 84: 230-238.
[142]
Che HL, M Muthiah, Y Ahn, S Son, WJ Kim, H Seonwoo, JH Chung, CS Cho and IK Park
(2011). Biodegradable particulate delivery of vascular endothelial growth factor plasmid from
polycaprolactone/polyethylenimine electrospun nanofibers for the treatment of myocardial
infarction. Journal for Nanoscience and Nanotechnology 11: 7073-7077.
[143]
Ito Y, H Tsurushima, M Sato, A Ito, A Oyane, Y Sogo and A Matsumura (2013). Angiogenesis
therapy for brain infarction using a slow-releasing drug delivery system for fibroblast growth
factor 2. Biochemical and Biophysical Research Communications 432: 182-187.
[144]
Geuze RE, LF Theyse, DH Kempen, HA Hazewinkel, HY Kraak, FC Oner, WJ Dhert and J
Alblas (2012). A differential effect of bone morphogenetic protein-2 and vascular endothelial
growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal
model. Tissue Engineering Part A 18: 2052-2062.
[145]
Solorio LD, CD Dhami, PN Dang, EL Vieregge and E Alsberg (2012). Spatiotemporal regula-
tion of chondrogenic differentiation with controlled delivery of transforming growth factor-
beta1 from gelatin microspheres in mesenchymal stem cell aggregates. Stem Cells Translational
Medicine 1: 632-639.
[146]
Song B, J Song, S Zhang, MA Anderson, Y Ao, CY Yang, TJ Deming and MV Sofroniew
(2012). Sustained local delivery of bioactive nerve growth factor in the central nervous system
via tunable diblock copolypeptide hydrogel depots. Biomaterials 33: 9105-9116.
[147]
Princz MA and H Sheardown (2012). Heparin-modified dendrimer crosslinked collagen
matrices for the delivery of heparin-binding epidermal growth factor. Journal of Biomedical
Materials Research A 100: 1929-1937.
[148]
Narmada BC, Y Kang, L Venkatraman, Q Peng, RB Sakban, B Nugraha, X Jiang, RM Bunte,
PT So, L Tucker-Kellogg,
et al
. (2013). Hepatic stellate cell-targeted delivery of hepatocyte
growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress
dimethylnitrosamine-induced liver fibrosis. Human Gene Therapy 24: 508-519.
[149]
Ueshima K, K Kitaoka, J Nakase, Q Xu, K Matsumoto and H Tsuchiya (2011). Promotion of
rabbit ligament healing by local delivery of hepatocyte growth factor. Journal of Orthopaedic
Science 16: 451-457.
[150]
Nakase J, K Kitaoka, K Matsumoto and K Tomita (2010). Facilitated tendon-bone healing by
local delivery of recombinant hepatocyte growth factor in rabbits. Arthroscopy 26: 84-90.
[151]
Jiang B, G Zhang and EM Brey (2013). Dual delivery of chlorhexidine and platelet-derived growth
factor-BB for enhanced wound healing and infection control. Acta Biomaterialia 9: 4976-4984.
